Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|March 2, 2019
Remarkable Improvement of the Catalytic Performance of PtFe Nanoparticles by Structural Ordering and DopingYang He, Yan Lin Wu, Xin Xing Zhu, et al.
Plos One|June 20, 2017
Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of ErlotinibChun-Zhi Ai, Yong Liu, Wei Li, et al.
Oncotarget|May 1, 2018
Correction: Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cellsXin-Xing Zhu, Ya-Wei Yan, Demeng Chen, et al.
Bone Research|September 29, 2017
AFF1 and AFF4 differentially regulate the osteogenic differentiation of human MSCsChen-Chen Zhou, Qiu-Chan Xiong, Xin-Xing Zhu, et al.
Bone Research|April 8, 2020
Correction to: AFF1 and AFF4 differentially regulate the osteogenic differentiation of human MSCsChen-Chen Zhou, Qiu-Chan Xiong, Xin-Xing Zhu, et al.
Oncotarget|August 28, 2016
Long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cellsXin-Xing Zhu, Ya-Wei Yan, Demeng Chen, et al.
Oncotarget|April 28, 2017
Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancerXin-Xing Zhu, Ya-Wei Yan, Chun-Zhi Ai, et al.
Cancer Cell International|November 23, 2017
CBFA2T2 is associated with a cancer stem cell state in renal cell carcinomaDu-Chu Chen, You-De Liang, Liang Peng, et al.
Cancer Cell International|May 22, 2018
Correction to: CBFA2T2 is associated with a cancer stem cell state in renal cell carcinomaDu-Chu Chen, You-De Liang, Liang Peng, et al.
Bone Research|April 13, 2018
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcomaDemeng Chen, Zhiqiang Zhao, Zixin Huang, et al.
Pageof 1